Ticker · CUSIP 37733W204

GSK

ADR
GSK PLC
Healthcare·Drug Manufacturers - General
···Share
Holders (tracked)
18
Combined shares
132,002,742
Combined value
$6.09B
Last close
$57.13
Quarter
2025Q4
Tracked holders · last 8 quarters
+5 vs previous quarter over the last 8.
18172024Q12025Q4
Price is +23.9% vs the avg quarter-end implied price across tracked holders.

SEC event timeline

24 events
  1. AQR Capital Management added2026-02-17
    +32,996 shares · 2025Q4
    13F
  2. Ken Griffin (Citadel Advisors) opened position2026-02-17
    +214,099 shares · 2025Q4
    13F
  3. Wellington Management added2026-02-17
    +9,137,167 shares · 2025Q4
    13F
  4. Paul Tudor Jones (Tudor Investment) opened position2026-02-17
    +29,500 shares · 2025Q4
    13F
  5. Jeremy Grantham (GMO) added2026-02-17
    +917,248 shares · 2025Q4
    13F
  6. D.E. Shaw & Co. opened position2026-02-17
    +5,544 shares · 2025Q4
    13F
  7. Two Sigma Investments trimmed2026-02-17
    −53,200 shares · 2025Q4
    13F
  8. Izzy Englander (Millennium Mgmt) trimmed2026-02-17
    −21,385 shares · 2025Q4
    13F
  9. Steve Cohen (Point72) opened position2026-02-17
    +1,474,951 shares · 2025Q4
    13F
  10. T. Rowe Price trimmed2026-02-17
    −57,283 shares · 2025Q4
    13F
  11. Dodge & Cox trimmed2026-02-13
    −9,885,765 shares · 2025Q4
    13F
  12. Ray Dalio (Bridgewater Associates) added2026-02-13
    +14,770 shares · 2025Q4
    13F
  13. Renaissance Technologies trimmed2026-02-12
    −952,381 shares · 2025Q4
    13F
  14. Ken Fisher (Fisher Asset Mgmt) added2026-02-09
    +968,370 shares · 2025Q4
    13F
  15. AQR Capital Management added2025-11-14
    +150,316 shares · 2025Q3
    13F
  16. T. Rowe Price trimmed2025-11-14
    −94,380 shares · 2025Q3
    13F
  17. Wellington Management added2025-11-14
    +1,965,611 shares · 2025Q3
    13F
  18. Izzy Englander (Millennium Mgmt) trimmed2025-11-14
    −13,437 shares · 2025Q3
    13F
  19. Ray Dalio (Bridgewater Associates) added2025-11-13
    +57,713 shares · 2025Q3
    13F
  20. Jeremy Grantham (GMO) trimmed2025-11-13
    −29,449 shares · 2025Q3
    13F
  21. Renaissance Technologies trimmed2025-11-13
    −262,900 shares · 2025Q3
    13F
  22. Norges Bank (Norway SWF) exited2025-11-13
    −55,000 shares · 2025Q3
    13F
  23. Dodge & Cox trimmed2025-11-13
    −354,135 shares · 2025Q3
    13F
  24. Ken Fisher (Fisher Asset Mgmt) added2025-11-12
    +889,210 shares · 2025Q3
    13F

Insider activity

No insider transactions in the last 30 days.
View full insider history for GSK →
Follow-the-investor returns
If you'd copied each holder of GSK…
Cost basis inferred from 13F share-delta history. Sorted by % return on the position they're still holding.
InvestorFirst inCost basisReturnPosition value today
T. Rowe Price2022Q3$0.03+184496.7%$451.0M
Dodge & Cox2022Q3$10.12+464.5%$3.91B
Renaissance Technologies2022Q3$15.93+258.7%$59.2M
Ken Fisher (Fisher Asset Mgmt)2022Q3$24.46+133.6%$1.90B
Two Sigma Investments2022Q3$29.01+96.9%$2.1M
Ray Dalio (Bridgewater Associates)2022Q3$36.14+58.1%$80.9M
D.E. Shaw & Co.2022Q3$37.96+50.5%$317K
Jeremy Grantham (GMO)2022Q3$39.90+43.2%$199.3M
AQR Capital Management2024Q1$43.14+32.4%$13.5M
Izzy Englander (Millennium Mgmt)2022Q3$44.03+29.7%$2.5M
Izzy Englander (Millennium Mgmt)2022Q3$44.03+29.7%$2.5M
Wellington Management2022Q3$45.43+25.7%$717.4M
Paul Tudor Jones (Tudor Investment)2022Q3$46.07+24.0%$1.4M
Paul Tudor Jones (Tudor Investment)2022Q3$46.07+24.0%$1.4M
Ken Griffin (Citadel Advisors)2022Q3$46.29+23.4%$27.7M
Ken Griffin (Citadel Advisors)2022Q3$46.29+23.4%$27.7M
Ken Griffin (Citadel Advisors)2022Q3$46.29+23.4%$27.7M
Steve Cohen (Point72)2022Q3$48.16+18.6%$84.3M

Who moved on this name in 2025Q4

13F transactions reported for the latest quarter, grouped by direction.
New positions4
Added to5
Trimmed5
Exited0
—

Institutional ownership over time

Distinct super-investors holding this ticker · combined dollar value, by quarter.
QuarterHoldersCombined value
2022Q3
23
$9.8M
2022Q4
21
$2.74B
2023Q1
19
$3.12B
2023Q2
16
$3.20B
2023Q3
15
$3.28B
2023Q4
16
$3.35B
2024Q1
17
$3.95B
2024Q2
15
$3.79B
2024Q3
17
$4.07B
2024Q4
17
$3.38B
2025Q1
17
$4.63B
2025Q2
18
$4.62B
2025Q3
13
$5.29B
2025Q4
18
$6.09B
Congress members trading this stock
DateMemberTypeAmount rangeFiling
2025-10-31Lisa McClainSell$1K – $15KPDF ↗
2025-10-30Lisa McClainSell$1K – $15KPDF ↗
2025-10-30Lisa McClainBuy$1K – $15KPDF ↗
2025-09-23Valerie HoyleSell$1K – $15KPDF ↗
2025-08-04Lisa McClainBuy$1K – $15KPDF ↗
2025-07-28Robert B. AderholtSell$1K – $15KPDF ↗
2025-06-24Lisa McClainSell$1K – $15KPDF ↗
2025-06-17Lisa McClainBuy$1K – $15KPDF ↗
2025-04-21Bruce WestermanSell$1K – $15KPDF ↗
2025-03-03Bruce WestermanBuy$1K – $15KPDF ↗
2024-11-18Valerie HoyleBuy$1K – $15KPDF ↗

Who owns GSK

18 super-investors · 2025Q4
Tracked stake
132.00M
shares
Combined value
$6.09B
% of shares outstanding
—
shares-out unknown
Quarter action mix
New7Added5Trim6
#ManagerSharesValue
1Dodge & Cox68.52M$3.36B
2Ken Fisher
Fisher Asset Mgmt
33.20M$1.63B
3Wellington Management12.56M$616M
4Jeremy Grantham
GMO
3.49M$171M
5Steve Cohen
Point72
1.47M$72M
6Ray Dalio
Bridgewater Associates
1.42M$69M
7Renaissance Technologies1.04M$51M
8Ken Griffin
Citadel Advisors
720.1K$35M
9Izzy Englander
Millennium Mgmt
649.4K$32M
10Ken Griffin
Citadel Advisors
485.0K$24M
11AQR Capital Management236.6K$12M
12Ken Griffin
Citadel Advisors
214.1K$10M
13Izzy Englander
Millennium Mgmt
43.6K$2M
14Two Sigma Investments36.3K$2M
15Paul Tudor Jones
Tudor Investment
24.9K$1M
16T. Rowe Price7.89M$387K
17D.E. Shaw & Co.5.5K$272K
18Paul Tudor Jones
Tudor Investment
4.6K$226K

Recent moves

20 transactions
Embed this chart
Paste this iframe anywhere to embed the live GSK chart.
<iframe src="https://openstocks.me/embed/stock/GSK" width="100%" height="480" frameborder="0" loading="lazy" title="GSK chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>
Preview: https://openstocks.me/embed/stock/GSK